30 Years of Innovation and Dedication to Women’s Health
Dr. Joseph Monsonego is a globally recognized gynecologist and pioneer in cervical cancer prevention. As one of the first to promote the concept of preventing cervical cancer by identifying its causative agent, the Human Papillomavirus (HPV), he has spent over three decades driving innovation in the fight against this disease. His groundbreaking work includes major contributions to the development of the HPV vaccine, for which he received the Prix Galien du Médicament.
A Visionary in HPV Research
With a passion for progress, Dr. Monsonego spearheaded international research programs, coordinating clinical trials in France and worldwide. His dedication reshaped medical practices and addressed widespread skepticism, always grounded in ethical values and patient care. Beyond his research, he has spent 80% of his career providing direct patient care, reflecting his commitment to making a tangible difference in women’s lives.
Driving Education and Prevention
Believing that cervical cancer is entirely preventable, Dr. Monsonego has tirelessly worked to educate both healthcare professionals and the public. His expertise in molecular biology and oncology has been instrumental in explaining HPV-related cancer mechanisms, fostering greater awareness and responsibility. He has authored over 300 peer-reviewed publications, ten scientific books, and numerous training programs that continue to guide practitioners worldwide.
Innovation for the Future
Recognizing the need for advanced tools, Dr. Monsonego recently developed a cutting-edge Artificial Intelligence model leveraging his 30 years of expertise. This innovation supports physicians in predicting pre-cancerous and cancerous risks, reducing unnecessary procedures, and enhancing decision-making in clinical practice.
A Global Legacy
As the founder and president of EUROGIN (European Research Organization on Genital Infection and Neoplasia), Dr. Monsonego has created a platform for international collaboration in HPV research. With over 2,500 participants at its latest congress, EUROGIN has become a global reference in cervical cancer prevention, shaping guidelines and recommendations worldwide.
Through groundbreaking research, educational advocacy, and technological innovation, Dr. Joseph Monsonego continues to redefine cervical cancer prevention, ensuring a safer and healthier future for women everywhere.